Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

This study is not yet open for participant recruitment.
Verified November 2013 by Stanford University
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01985399
First received: November 4, 2013
Last updated: November 8, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)